Cargando…

Design strategy for serine hydroxymethyltransferase probes based on retro-aldol-type reaction

Serine hydroxymethyltransferase (SHMT) is an enzyme that catalyzes the reaction that converts serine to glycine. It plays an important role in one-carbon metabolism. Recently, SHMT has been shown to be associated with various diseases. Therefore, SHMT has attracted attention as a biomarker and drug...

Descripción completa

Detalles Bibliográficos
Autores principales: Nonaka, Hiroshi, Nakanishi, Yuki, Kuno, Satoshi, Ota, Tomoki, Mochidome, Kentaro, Saito, Yutaro, Sugihara, Fuminori, Takakusagi, Yoichi, Aoki, Ichio, Nagatoishi, Satoru, Tsumoto, Kouhei, Sando, Shinsuke
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6382819/
https://www.ncbi.nlm.nih.gov/pubmed/30787298
http://dx.doi.org/10.1038/s41467-019-08833-7
Descripción
Sumario:Serine hydroxymethyltransferase (SHMT) is an enzyme that catalyzes the reaction that converts serine to glycine. It plays an important role in one-carbon metabolism. Recently, SHMT has been shown to be associated with various diseases. Therefore, SHMT has attracted attention as a biomarker and drug target. However, the development of molecular probes responsive to SHMT has not yet been realized. This is because SHMT catalyzes an essential yet simple reaction; thus, the substrates that can be accepted into the active site of SHMT are limited. Here, we focus on the SHMT-catalyzed retro-aldol reaction rather than the canonical serine–glycine conversion and succeed in developing fluorescent and (19)F NMR molecular probes. Taking advantage of the facile and direct detection of SHMT, the developed fluorescent probe is used in the high-throughput screening for human SHMT inhibitors, and two hit compounds are obtained.